Invention Grant
- Patent Title: 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same
-
Application No.: US17258682Application Date: 2019-07-26
-
Publication No.: US11958812B2Publication Date: 2024-04-16
- Inventor: Taichi Takahashi , Hisayuki Takamatsu , Daisuke Iijima , Shuzo Takeda
- Applicant: MITSUBISHI TANABE PHARMA CORPORATION
- Applicant Address: JP Osaka
- Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee Address: JP Osaka
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP 18141254 2018.07.27
- International Application: PCT/JP2019/029366 2019.07.26
- International Announcement: WO2020/022470A 2020.01.30
- Date entered country: 2021-01-07
- Main IPC: C07D237/14
- IPC: C07D237/14 ; A61P11/00 ; C07D213/89 ; C07D237/08 ; C07D401/04 ; C07D413/04
Abstract:
Provided is a compound superior in an ATX inhibitory action and useful for the prophylaxis or treatment of diseases involving ATX. A carboxylic acid compound represented by the following formula (1) or a pharmacologically acceptable salt thereof:
wherein each symbol is as defined in the SPECIFICATION.
wherein each symbol is as defined in the SPECIFICATION.
Public/Granted literature
Information query
